BEIJING, Sept. 10, 2015 /PRNewswire/ -- China Biologic
Products, Inc. (NASDAQ: CBPO)
("China Biologic" or the "Company"), a leading fully
integrated plasma-based biopharmaceutical company in China, today announced that the Company will
participate in the following investor conferences in September 2015:
On September 10-11, 2015, China
Biologic will participate in the Deutsche Bank 14th
Annual Global Emerging Markets One-on-One Conference at The Waldorf
Astoria in New York.
On September 15, 2015, China
Biologic will participate in the 2015 Morgan Stanley Asia Pacific
Healthcare Day at the Boston Harbor Hotel in Boston.
On September 16-17, 2015, China
Biologic will participate in the 2015 Morgan Stanley Global
Healthcare Conference at the Grand Hyatt New York in New York.
Mr. David Gao, Chairman and Chief
Executive Officer, Mr. Ming Yang,
Chief Financial Officer, and Mr. Ming
Yin, Senior Vice President of China Biologic, will present
and meet with investors at these events. For additional information
or interest in meeting with management, please contact the
institutional sales representative at each respective bank.
About China Biologic Products, Inc.
China Biologic is a leading plasma-based biopharmaceutical
company in China. The Company's
products are used as critical therapies during medical emergencies
and for the prevention and treatment of life-threatening diseases
and immune-deficiency related diseases. China Biologic is
headquartered in Beijing and
manufactures over 20 different dosages of plasma-based products
through its indirect majority-owned subsidiaries, Shandong Taibang
Biological Products Co., Ltd. and Guizhou Taibang Biological
Products Co., Ltd. The Company also has an equity investment in
Xi'an Huitian Blood Products Co., Ltd. The Company sells its
products to hospitals and inoculation centers, as well as
distributors, in China. For
additional information, please see the Company's website,
www.chinabiologic.com.
Contact:
China Biologic Products, Inc.
Mr. Ming Yin
Senior Vice President
Phone: +86-10-6598-3099
Email: ir@chinabiologic.com
ICR Inc.
Mr. Bill Zima
Phone: +86-10-6583-7511 or +1-646-405-5191
E-mail: bill.zima@icrinc.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/china-biologic-to-attend-upcoming-investor-conferences-300140674.html
SOURCE China Biologic Products, Inc.